AI summary · may contain errors
Bacterial peptidoglycan (PGN) activates hepatocyte mitophagy and reduces liver fibrosis in a CCL 4-induced model, with p62 (SQSTM1) required for the response.
- Open access
- 1 cites
Moving in Hepatology, Journal of Hepatology, Cellular and Molecular Gastroenterology and Hepatology, Gut, bioRxiv, Nature Communications, Cell Reports and EMBO Molecular Medicine.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Bacterial peptidoglycan (PGN) activates hepatocyte mitophagy and reduces liver fibrosis in a CCL 4-induced model, with p62 (SQSTM1) required for the response.
AI summary · may contain errors
MAIT cells drive early fibrogenesis in the carbon tetrachloride mouse model, exacerbating myofibroblast activation and matrix deposition during fibrosis initiation.
AI summary · may contain errors
Lentiviral delivery of Csi-miR-71a in a CCl4-induced mouse model alleviates liver fibrosis by directly targeting Scube3 and suppressing TGF-β/Smad and PI3K/AKT signaling.
AI summary · may contain errors
Aquitalea magnusonii translocation across the intestinal barrier is linked to systemic inflammation and liver fibrosis in chronic liver disease models, including ACLF-associated metabolite production.
AI summary · may contain errors
Deleting FANIN (Zfp148) in Mus Musculus causes loss of Foxa1 and Foxa2 expression in liver, linked to global chromatin accessibility changes at HNF4α motif–enriched regions.
AI summary · may contain errors
Hepatocyte-specific loss of ATM in a preclinical MASLD model significantly worsens liver damage and fibrosis by triggering mitochondrial hypermetabolism and a bioenergetic crisis.
AI summary · may contain errors
RBM34 is markedly upregulated in human and murine fibrotic livers, where it enhances DROSHA-mediated nuclear export and translation of Loxl2 mRNA in activated hepatic stellate cells.
AI summary · may contain errors
Progressive fibrosis is linked to a self-sustaining mesoscale fibrotic tissue module, where retained cellular plasticity is misdirected toward maladaptive repair.
AI summary · may contain errors
Exogenous-serine–dependent pancreatic ductal adenocarcinoma cells reprogram mouse hepatocytes via a CXCL5–CXCR2 axis, boosting PHGDH-driven serine production that supports liver metastasis outgrowth.
AI summary · may contain errors
Stem cell and hepatocyte transplantation, plus liver organoid and 3D bioprinting approaches, are linked to improved outcomes and new graft sources for end-stage liver disease.
AI summary · may contain errors
B-BEST targeted sc/snRNA-seq resolves HBV replication-state heterogeneity in HBV-positive hepatocytes, linking specific host metabolic/mitochondrial programs to active viral transcription in HBeAg-positive patients.
AI summary · may contain errors
Cirrhosis is a dynamic, modifiable disease state in which sustained aetiological control can induce meaningful architectural remodelling, but regression often leaves residual vascular dysfunction and oncogenic risk.
AI summary · may contain errors
Pericytes are the primary endogenous source of hepatocyte growth factor (HGF) in healthy pancreatic islets, and pericyte-derived HGF is required for normal glucose homeostasis.
AI summary · may contain errors
Hepatic sympathetic activity rises and hepatic sympathetic innervation diminishes as MASLD advances, linking altered hepatic neural balance to progression toward worse liver outcomes.
AI summary · may contain errors
Systemic metabolic dysfunction is translated into MASLD progression through imbalanced insulin and glucagon, which disrupt glucose and lipid fluxes and promote hepatocellular stress and fibrosis.
AI summary · may contain errors
Myeloid CD36 deficiency in fibrotic mouse livers promotes macrophage adaptive immunity, linked to restored MHC-I antigen presentation and CD8+ T cell activation.
AI summary · may contain errors
In early and advanced metabolic dysfunction-associated steatotic liver disease, platelets show heightened metabolic activity and altered reactivity, including oxPAPC-linked mitochondrial reprogramming.
AI summary · may contain errors
Hepatic GPR75 protein levels rise significantly during MASH, and altering Gpr75 in mice strongly modulates diet-induced steatosis, MASH, and liver fibrosis.
AI summary · may contain errors
Anserine supplementation restores antibacterial immunity in cirrhotic mice by reconstituting hepatocyte CCL5–mediated recruitment of CD44+ plasmacytoid dendritic cells, reducing bacterial burden and mortality.
AI summary · may contain errors
Aripiprazole prevents progression of MASH-induced hepatocellular carcinoma in rats, linked to antifibrogenic and anti-inflammatory modulation of liver fibroblasts and macrophages.
AI summary · may contain errors
On-demand TACE plus atezolizumab and bevacizumab improved investigator-assessed TACE-PFS to 11·30 months versus 7·03 months with on-demand TACE alone in unresectable intermediate-to-high HCC.
Journals this month
Topics moving, week to 17 Nov 2026
By field